Politics

Medical Marijuana Advocates Outraged Over Georgia PTSD Bill

Published on March 20, 2018 · Last updated July 28, 2020
The golden capital dome stands out against a blue sky in Atlanta flags waving

ATLANTA (AP) — Medical marijuana advocates expressed outrage Monday over the apparent stalling of a proposal that would expand Georgia’s low-THC medical cannabis oil program to include those with post-traumatic stress disorder or chronic, intractable pain.

Members of the Georgia’s Hope advocacy group held a news conference inside the state Capitol and questioned why the bill, which passed the House overwhelmingly last month, hasn’t gotten a Senate committee hearing.

“This is what, our third study committee? I think we have enough evidence.”

Rep. David Clark, the bill’s sponsor, accused Lt. Gov. Casey Cagle, a leading Republican gubernatorial candidate and the president of the Senate, of “playing politics” and stifling the proposal by instead calling for another study committee on medical marijuana. He and other lawmakers who support the measure joined the news conference.

“This is what, our third study committee? I think we have enough evidence from the states that have passed this to know that it’s helping people,” Clark, a Buford Republican and Army veteran, told The Associated Press after the news conference.

Those suffering from PTSD who have access to cannabis oil are less likely to turn to highly addictive opioid painkillers, Clark said.

There are currently nearly 4,000 Georgians who are legally allowed to have low-THC cannabis oil, although many have complained that it’s difficult to get access to it because it cannot be cultivated in the state, Rep. Allen Peake said.

In a statement, Cagle said he has supported previous legislation that expanded cannabis oil access. He also said he wants the study committee to examine how to make the medication more accessible to those with prescriptions.

“I’m committed to supporting responsible legislation that ensures Georgians who can benefit from this medication have safe, secure and reliable access,” Cagle said.

Sen. Renee Unterman is the chairwoman of the Health and Human Services committee, where Clark’s proposal has languished. Unterman said the bill is likely dead for this legislative session, which ends March 29. She said she is instead focused on expanding accessibility through the study committee.

Two of Cagle’s Republican rivals in the race, Clay Tippins and Sen. Michael Williams, attended the news conference in support of the bill.

Tippins, a businessman and former Navy SEAL, also used it as an opportunity to blast Cagle.

“(Proposing a study committee) is taking an important issue in an election year, giving it lip service and quietly killing it and acting like something is being done,” Tippins said.

Shop highly rated dispensaries near you

Showing you dispensaries near
See all dispensaries

After the news conference, a group of advocates filed into Cagle’s office to confront him about the issue. Cagle’s personal assistant told the group that Cagle was busy the rest of the day, but that they could call to schedule a meeting later on the issue.

Shop highly rated dispensaries near you

Showing you dispensaries near
See all dispensaries
The Associated Press
The Associated Press
The AP is one of the world's largest and most trusted sources of independent newsgathering.
View The Associated Press's articles
Get good reads, local deals, and strain spotlights delivered right to your inbox.

By providing us with your email address, you agree to Leafly's Terms of Service and Privacy Policy.



Stay In Touch

Receive updates on new products, special offers, and industry news.

By providing us with your email address, you agree to Leafly's Terms of Service and Privacy Policy.

Leafly mobile app
Get high for less.
Download the Leafly app.
Download Leafly: Marijuana Reviews on the App Store
Download Leafly Marijuana Reviews on Google Play




* Statements made on this website have not been evaluated by the U.S. Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease. Information provided by this website or this company is not a substitute for individual medical advice.


© 2024 Leafly, LLC
Leafly and the Leafly logo are registered trademarks of Leafly, LLC. All Rights Reserved.